Jacobs alleges that the cafe outright refused to seat her at ‘a nicely placed empty table’ towards the front of the cafe and instead told her to sit at a table near the back. The newsreader ...

In the scathing Instagram Story, Jacobs claimed the Melbourne cafe refused to seat her at the table she wanted in a prime spot. Instead, they seated her in the back of the venue, “only to offer ...

Jacob Burn Film Center’s new bar and café adds to the moviegoing experience with a selection of locally sourced food and beverages. Photo by Ed Cody. Courtesy of Jacob Burns Film Center. In the past ...

This was a Marc Jacobs show that was over before it began. The models did two finale laps and then Jacobs was out taking his bow. It was all over in about three minutes. A comment on the ...

MedImmune’s vice president of research and head of oncology R&D Ronald Herbst, Ph.D., has followed a series of other AstraZeneca and its biologics arm staffers out the door. No, not to ...

By Andrew Pollack The $15.6 billion deal to acquire MedImmune is perhaps the most emphatic sign yet of the push by big drug makers into biotechnology. David M. Mott, the chief executive of ...

After 30 years of drug development, MedImmune will cease to exist as an industry name now that owner AstraZeneca has decided to retire the brand as part of ongoing restructuring efforts. The decision ...

MedImmune will create a standalone company for early-stage inflammatory and autoimmunity biologics. Here are five things to know. 1. MedImmune is the global biologics research and development arm of ...

AstraZeneca's biologics research and development arm MedImmune and US life sciences group Abpro have spun out a new company to advance development of a preclinical, novel bispecific antibody targeting ...

AstraZeneca's biologics division MedImmune is partnering with life sciences technology provider Abpro to develop a preclinical drug targeting two proteins related to tumor development. Neither company ...